These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29258548)

  • 21. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.
    Tsao CY
    Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.
    Belaya K; Rodríguez Cruz PM; Liu WW; Maxwell S; McGowan S; Farrugia ME; Petty R; Walls TJ; Sedghi M; Basiri K; Yue WW; Sarkozy A; Bertoli M; Pitt M; Kennett R; Schaefer A; Bushby K; Parton M; Lochmüller H; Palace J; Muntoni F; Beeson D
    Brain; 2015 Sep; 138(Pt 9):2493-504. PubMed ID: 26133662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of salbutamol monotherapy in slow-channel congenital myasthenic syndrome caused by a novel mutation in CHRND.
    Tawara N; Yamashita S; Takamatsu K; Yamasaki Y; Mukaino A; Nakane S; Farshadyeganeh P; Ohno K; Ando Y
    Muscle Nerve; 2021 Apr; 63(4):E30-E32. PubMed ID: 33428214
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pathophysiological characterization of congenital myasthenic syndromes: the example of mutations in the MUSK gene].
    Chevessier F; Faraut B; Ravel-Chapuis A; Richard P; Gaudon K; Bauché S; Prioleau C; Herbst R; Goillot E; Ioos C; Azulay JP; Attarian S; Leroy JP; Fournier E; Legay C; Schaeffer L; Koenig J; Fardeau M; Eymard B; Pouget J; Hantaï D
    J Soc Biol; 2005; 199(1):61-77. PubMed ID: 16114265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia.
    Ben Ammar A; Soltanzadeh P; Bauché S; Richard P; Goillot E; Herbst R; Gaudon K; Huzé C; Schaeffer L; Yamanashi Y; Higuchi O; Taly A; Koenig J; Leroy JP; Hentati F; Najmabadi H; Kahrizi K; Ilkhani M; Fardeau M; Eymard B; Hantaï D
    PLoS One; 2013; 8(1):e53826. PubMed ID: 23326516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New mutation in the β1 propeller domain of LRP4 responsible for congenital myasthenic syndrome associated with Cenani-Lenz syndrome.
    Masingue M; Cattaneo O; Wolff N; Buon C; Sternberg D; Euchparmakian M; Boex M; Behin A; Mamchaouhi K; Maisonobe T; Nougues MC; Isapof A; Fontaine B; Messéant J; Eymard B; Strochlic L; Bauché S
    Sci Rep; 2023 Aug; 13(1):14054. PubMed ID: 37640745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Null variants in AGRN cause lethal fetal akinesia deformation sequence.
    Geremek M; Dudarewicz L; Obersztyn E; Paczkowska M; Smyk M; Sobecka K; Nowakowska B
    Clin Genet; 2020 Apr; 97(4):634-638. PubMed ID: 31730230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates.
    Belaya K; Finlayson S; Slater CR; Cossins J; Liu WW; Maxwell S; McGowan SJ; Maslau S; Twigg SR; Walls TJ; Pascual Pascual SI; Palace J; Beeson D
    Am J Hum Genet; 2012 Jul; 91(1):193-201. PubMed ID: 22742743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin.
    Abicht A; Stucka R; Karcagi V; Herczegfalvi A; Horváth R; Mortier W; Schara U; Ramaekers V; Jost W; Brunner J; Janssen G; Seidel U; Schlotter B; Müller-Felber W; Pongratz D; Rüdel R; Lochmüller H
    Neurology; 1999 Oct; 53(7):1564-9. PubMed ID: 10534268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological and morphological characterization of a case of autosomal recessive congenital myasthenic syndrome with acetylcholine receptor deficiency due to a N88K rapsyn homozygous mutation.
    Yasaki E; Prioleau C; Barbier J; Richard P; Andreux F; Leroy JP; Dartevelle P; Koenig J; Molgó J; Fardeau M; Eymard B; Hantaï D
    Neuromuscul Disord; 2004 Jan; 14(1):24-32. PubMed ID: 14659409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain.
    Logan CV; Cossins J; Rodríguez Cruz PM; Parry DA; Maxwell S; Martínez-Martínez P; Riepsaame J; Abdelhamed ZA; Lake AV; Moran M; Robb S; Chow G; Sewry C; Hopkins PM; Sheridan E; Jayawant S; Palace J; Johnson CA; Beeson D
    Am J Hum Genet; 2015 Dec; 97(6):878-85. PubMed ID: 26626625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital myasthenic syndromes: recent advances.
    Beeson D
    Curr Opin Neurol; 2016 Oct; 29(5):565-71. PubMed ID: 27472506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural abnormalities of the AChR caused by mutations underlying congenital myasthenic syndromes.
    Beeson D; Webster R; Ealing J; Croxen R; Brownlow S; Brydson M; Newsom-Davis J; Slater C; Hatton C; Shelley C; Colquhoun D; Vincent A
    Ann N Y Acad Sci; 2003 Sep; 998():114-24. PubMed ID: 14592868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR.
    Zoltowska K; Webster R; Finlayson S; Maxwell S; Cossins J; Müller J; Lochmüller H; Beeson D
    Hum Mol Genet; 2013 Jul; 22(14):2905-13. PubMed ID: 23569079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MUSK, a new target for mutations causing congenital myasthenic syndrome.
    Chevessier F; Faraut B; Ravel-Chapuis A; Richard P; Gaudon K; Bauché S; Prioleau C; Herbst R; Goillot E; Ioos C; Azulay JP; Attarian S; Leroy JP; Fournier E; Legay C; Schaeffer L; Koenig J; Fardeau M; Eymard B; Pouget J; Hantaï D
    Hum Mol Genet; 2004 Dec; 13(24):3229-40. PubMed ID: 15496425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A severe congenital myasthenic syndrome with "dropped head" caused by novel MUSK mutations.
    Giarrana ML; Joset P; Sticht H; Robb S; Steindl K; Rauch A; Klein A
    Muscle Nerve; 2015 Oct; 52(4):668-73. PubMed ID: 25900532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Splicing regulation and dysregulation of cholinergic genes expressed at the neuromuscular junction.
    Ohno K; Rahman MA; Nazim M; Nasrin F; Lin Y; Takeda JI; Masuda A
    J Neurochem; 2017 Aug; 142 Suppl 2():64-72. PubMed ID: 28072465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of mutations in the MYO9A gene in patients with congenital myasthenic syndrome.
    O'Connor E; Töpf A; Müller JS; Cox D; Evangelista T; Colomer J; Abicht A; Senderek J; Hasselmann O; Yaramis A; Laval SH; Lochmüller H
    Brain; 2016 Aug; 139(Pt 8):2143-53. PubMed ID: 27259756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A newly identified chromosomal microdeletion and an N-box mutation of the AChR epsilon gene cause a congenital myasthenic syndrome.
    Abicht A; Stucka R; Schmidt C; Briguet A; Höpfner S; Song IH; Pongratz D; Müller-Felber W; Ruegg MA; Lochmüller H
    Brain; 2002 May; 125(Pt 5):1005-13. PubMed ID: 11960891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital myasthenic syndromes and the formation of the neuromuscular junction.
    Beeson D; Webster R; Cossins J; Lashley D; Spearman H; Maxwell S; Slater CR; Newsom-Davis J; Palace J; Vincent A
    Ann N Y Acad Sci; 2008; 1132():99-103. PubMed ID: 18567858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.